Linc AB
Stockholmlinc.se
Overview
Linc AB is a Swedish investment firm that invests in product-oriented companies in the Nordic life science industry, primarily focusing on pharmaceuticals and medical technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Gesynta Pharma AB | Jul 2025 | Series B | Co-investor |
| Gesynta Pharma AB | Jan 2025 | Series B | Co-investor |
| Akiram Therapeutics | Jan 2023 | Series A | Co-investor |
| Melius Pharma | May 2022 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.